化疗联合手术治疗耐药性妊娠滋养细胞肿瘤的临床分析

doi:10.11904/j.issn.1002-3070.2020.01.010

摘要/Abstract

摘要： 目的探究化疗联合手术治疗耐药性妊娠滋养细胞肿瘤(Gestational trophoblastic neoplasia,GTN)患者的临床效果。方法选择耐药的高危型GTN患者76例,随机分为对照组和研究组,各38例;对照组使用足叶乙甙+甲氨蝶呤+放线菌素D/足叶乙甙,顺铂(etoposide,methotrexate,and actinomycin-D/etoposide and cisplatin,EMA/EP)方案化疗,研究组使用化疗联合手术治疗的方法治疗;比较两组的治疗效果、预后、外周血林白细胞亚群以及不良反应发生情况。结果治疗6个月后研究组的客观缓解率(Objective response rate,ORR)高于对照组,差异具有统计学意义(P=0.024);研究组的耐药率和复发率低于对照组(P＜0.05);治疗前两组血清人绒毛膜促性腺激素(Human chorionic gonadotropin,HCG)差异无统计学意义,治疗后两组HCG水平均降低(P＜0.001),治疗后6个月、12个月和末次随访研究组的血清HCG水平低于对照组(P＜0.001);治疗前两组外周血T细胞亚群水平差异无统计学意义,而治疗6个月后均有不同程度的改善;研究组的CD3⁺、CD4⁺和CD4⁺/CD8⁺T细胞高于对照组(P＜0.001);研究组的中性粒细胞减少、血红蛋白降低、恶心呕吐、脱发的发生率则低于对照组(P＜0.05)。结论对于一线耐药的高危GTN患者,化疗联合手术治疗具有更好的治疗效果,并可有效改善机体免疫水平,降低不良反应的发生。

关键词: 妊娠滋养细胞肿瘤, 化疗, EMA/EP方案, 客观缓解率

Abstract: Objective The Objective of this study was to explore the clinical effects of chemotherapy combined with surgery in patients with drug-resistant gestational trophoblastic neoplasia(GTN).Methods A total of 76 drug-resistant patients with high-risk GTN were selected and randomly divided into a control group and an observed group,each with 38 patients.Patients in the control group were treated with etoposide,methotrexate,and actinomycin-D/etoposide and cisplatin(EMA/EP),and patients in the observed group were treated with EMA/EP regimen combined with surgery.The treatment effect,prognosis,peripheral blood lymphocyte subsets and adverse reactions were compared between the control and observed groups.Results After 6 months of treatment,the ORR(Objective response rate)of the observed group was higher than that of the control group,and the difference was statistically significant(P=0.024).The drug resistance rate and recurrence rate in the observed group were lower than those in the control group(P＜0.05).There was no significant difference in serum HCG between the control and observed groups before treatment.The serum HCG levels in two groups decreased after treatment(P＜0.001).The serum HCG levels in the observed group at 6 months,12 months,and the last follow-up after treatment were lower than those in the control group(P＜0.001).There was no significant difference in the levels of T lymphocyte subsets between the two groups before treatment,and there were different degrees of improvement after 6 months of treatment.The CD3⁺,CD4⁺ and CD4⁺/CD8⁺T cells in the observed group were higher than those in the control group(P＜0.05).The incidence of neutropenia,hemoglobin reduction,nausea and vomiting,and hair loss in the observed group were lower than those in the control group(P＜0.05).Conclusion For patients with high-risk GTN in first-line drug-resistance,chemotherapy combined with surgery has a better therapeutic effect,and can effectively improve the body′s immune level and reduce the incidence of adverse reactions.

Key words: Gestational trophoblastic neoplasia, Chemotherapy, EMA/EP regimen, Objective response rate

中图分类号:

R737.33

李春梅, 李幼飞, 贾红梅. 化疗联合手术治疗耐药性妊娠滋养细胞肿瘤的临床分析[J]. 实用肿瘤学杂志, 2020, 34(1): 55-59.

LI Chunmei, LI Youfei, JIA Hongmei. Clinical analysis of chemotherapy combined with surgery for drug-resistant gestational trophoblastic tumors[J]. Journal of Practical Oncology, 2020, 34(1): 55-59.

参考文献

1 Shaaban AM,Rezvani M,Haroun RR,et al.Gestational trophoblastic disease:clinical and imaging features[J].Radiographics,2017,37(2):681-700.
2 Park JW,Bae JW.Epithelioid trophoblastic tumor in a postmenopausal woman:a case report[J].J Menopausal Med,2016,22(1):50-53.
3 Byun SW,Park TC,Bae SN.Conservative chemotherapy in gestational trophoblastic disease:experience with etoposide,methotrexate,and dactinomycin chemotherapy[J].Int J Gynecol Cancer,2016,26(4):790-795.
4 Sobecki-Rausch J,Winder A,Maniar KP,et al.Surgery and platinum/etoposide-based chemotherapy for the treatment of epithelioid trophoblastic tumor[J].Int J Gynecol Cancer,2018,28(6):1117-1122.
5 孔雨佳,向阳.高危及耐药性妊娠滋养细胞肿瘤患者的治疗策略[J].现代妇产科进展,2017,26(7):550-555.
6 陈纳泽,赵峻,向阳.含氟脲苷的多药联合化疗方案对妊娠滋养细胞肿瘤疗效评估研究[J].中国实用妇科与产科杂志.2017,33(5):507-511.
7 刘武,赵薇,张永清,等.依托泊苷+甲氨蝶呤+放线菌素D/环磷酰胺+长春新碱为初始方案治疗高危型妊娠滋养细胞肿瘤的疗效及相关因素分析[J].中华医学杂志,2018,98(47):3896-3899.
8 薛薇,杨隽钧,赵峻,等.化疗对妊娠滋养细胞肿瘤患者卵巢功能与生命质量的影响[J].中华妇产科杂志,2018,53(6):377-383.
9 田友兰.手术联合化疗治疗耐药性妊娠滋养细胞肿瘤的疗效分析[J].中国卫生标准管理,2015,6(4):227-228.
10 倪丽霞.手术联合化疗治疗耐药性妊娠滋养细胞肿瘤的疗效观察[J].中国医药指南,2016,14(35):67-68.
11 计鸣良,蒋诗阳,赵峻,等.有高危因素的妊娠滋养细胞肿瘤初始化疗方案疗效评估[J].中国实用妇科与产科杂志,2018,34(4):71-76.
12 常颖颖.手术在妊娠滋养细胞肿瘤治疗中的作用探讨[J].中国医药指南,2014,22(22):180-181.
13 Vilmos F,Ivan S,Janos S,et al.The role of surgery in the management of gestational trophoblastic neoplasia the hungarian experience[J].J Reprod Med,2016,61(5):197-204.
14 Zhao J,Lv WG,Feng FZ,et al.Placental site trophoblastic tumor:A review of 108 cases and their implications for prognosis and treatment[J].Gynecologic Oncology,2016,142(1):102-108.
15 闫震,段微.子宫病灶切除治疗妊娠滋养细胞肿瘤患者32例临床分析[J].中国临床医生杂志,2015,43(10):65-67.
16 Cai H,Zhou R,Liang W,et al.Dedifferentiated endometrioid adenocarcinoma with trophoblastic components and elevated serum alfa-fetoprotein:A case report and literature review.[J].Medicine(Baltimore),2018,97(17):e0551.
17 刘珈杞,刘耀华,陈鑫,等.CD4⁺CD25⁺Foxp3⁺Treg细胞调控肿瘤免疫抑制微环境的研究进展[J].实用肿瘤学杂志,2016,30(6):555-559.
18 叶新英,邓云刚,章新华,等.卡培他滨联合奥沙利铂对老年晚期结直肠癌患者免疫功能、生活质量及血清肿瘤标志物水平的影响[J].中国老年学杂志,2018,38(12):142-144.
19 刘海舟,卢海跃,张卫峰.复方斑蝥胶囊对乳腺癌术后化疗患者免疫功能的影响[J].中华中医药学刊,2016,1(1):125-128.

[1]	聂建, 陈公琰. 凝血指标在小细胞肺癌中的临床和预后价值:一项回顾性研究[J]. 实用肿瘤学杂志, 2020, 34(1): 49-54.
[2]	阮鹏, 谭爱丽. 血清中microRNA-127对鼻咽癌患者化疗抗性的预测价值[J]. 实用肿瘤学杂志, 2019, 33(6): 508-512.
[3]	李剑, 徐向英, 吕研. 局限期小细胞肺癌首程治疗失败后再程治疗的相关研究[J]. 实用肿瘤学杂志, 2019, 33(6): 519-524.
[4]	冯越,邢丽楠,王棹,张云艳. NLR与肿瘤同步放化疗预后的相关性研究[J]. 实用肿瘤学杂志, 2019, 33(3): 284-288.
[5]	梁虹, 李奇, 王耀先, 靳红, 王铜, 王亚楠, 段雅妮, 宋敏. 宫颈癌化疗心血管毒性预防的间断时间序列试验[J]. 实用肿瘤学杂志, 2019, 33(2): 134-138.
[6]	马志杰, 王帆, 赵亚双. 乳腺癌化疗患者生存质量及影响因素分析[J]. 实用肿瘤学杂志, 2019, 33(2): 149-154.
[7]	秦岚群, 邹征云. 恶性黑色素瘤化疗研究进展[J]. 实用肿瘤学杂志, 2019, 33(2): 167-172.
[8]	常晓霞综述, 宋冰冰, 刘家仁审校. 植物化学物增加肿瘤细胞对化疗药物敏感性的研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 67-72.
[9]	姜亮亮综述, 王晶审校. 上皮性卵巢癌远处转移的诊治进展[J]. 实用肿瘤学杂志, 2018, 32(5): 480-482.
[10]	张婷, 贾迪(综述), 杨丹(审校). 骨肉瘤的生物学治疗进展[J]. 实用肿瘤学杂志, 2018, 32(3): 254-257.
[11]	翟可可, 高媛媛, 冯晓, 许静文, 宫玉芳, 孟庆威. 术后辅助化疗后复发转移与初次诊断的IV期NSCLC一线化疗疗效分析[J]. 实用肿瘤学杂志, 2018, 32(2): 107-111.
[12]	杨文娟, 余静, 黄朝, 张俊红, 谢丛华. 化疗早期重度粒细胞下降与小细胞肺癌预后相关性分析[J]. 实用肿瘤学杂志, 2018, 32(1): 19-24.
[13]	黎玉娇, 尚乃舰. 影像学评估乳腺癌新辅助化疗反应的研究进展[J]. 实用肿瘤学杂志, 2018, 32(1): 63-67.
[14]	梁语丝, 谭永刚, 邹华伟审校. 低剂量化疗作用机制的研究进展[J]. 实用肿瘤学杂志, 2017, 31(6): 538-542.
[15]	石峰,于雁. 节拍化疗通过影响血管形成及免疫系统抑制肿瘤细胞生长的机制[J]. 实用肿瘤学杂志, 2017, 31(4): 316-320.